Show simple item record

dc.contributor.advisorGurtoo, Anjula
dc.contributor.authorBhasi, A B
dc.date.accessioned2015-02-05T09:41:20Z
dc.date.accessioned2018-07-31T06:34:15Z
dc.date.available2015-02-05T09:41:20Z
dc.date.available2018-07-31T06:34:15Z
dc.date.issued2015-02-05
dc.date.submitted2011
dc.identifier.urihttps://etd.iisc.ac.in/handle/2005/2435
dc.identifier.abstracthttp://etd.iisc.ac.in/static/etd/abstracts/3131/G25237-Abs.pdfen_US
dc.description.abstractIn the past few decades, there has been increasing concern towards the potential effects of industrial pollutants on our eco-system. Each country has developed and enacted stringent environmental regulatory standards to address this concern. Several studies conducted in the general area of regulatory impact show significant direct impact of these regulations on organizations. Pharmaceutical industry in particular, due to the generation of variety of hazardous waste during operations, is one among the highly regulated industrial sector globally. The financial liabilities and resource shortages associated while incorporating abatement technologies and related procedural changes make Pharmaceutical Small and Medium Enterprises (PSMEs) highly vulnerable to these regulatory compliance standards. This study aims to investigate two aspects of environment regulation compliance in the PSMEs, namely To identify the nature and magnitude of vulnerabilities encountered by the PSMEs in India while complying with environmental regulations, and To explore and to analyze the adaptation mechanisms followed by the PSMEs in India, while complying with environmental regulations. Literature explorations in the area of environmental regulation, enforcement, compliance, pharmaceutical industry and SMEs, gave limited studies with focus on India. Hence a questionnaire based survey was administered online and face to face. The sampling design followed was stratified random and the total sample size taken for the final analysis was 71. The survey targeted the senior executive officers of pharmaceutical firms across India. Unstructured discussions and interactions with experts in the field were also carried out to understand the gravity of each concern. Data was analyzed using the Analytic Hierarchy Process (AHP) for exploring and prioritizing vulnerability concerns, factor analysis for identifying the general adaptation mechanisms and systems practiced, and cluster analysis for assessing the underlying relationship among vulnerability concerns and adaptation patterns of firms under study. Findings of the analysis highlighted several significant drivers of the interaction between the PSMEs and the environment regulations. Some of them are as follows: One, conforming to literature finding, our study also found manufacturing related problems as the most significant concern for the PSMEs. However, unlike the Western countries, it was the poor quality of raw material available in the market that causes the main concern, and not the need for intensive capital investment in abatement technologies. Investigations revealed the steady global market decline for this sub-sector and the need for new innovations to meet the changing global trends. Two, marketing was a significantly higher concern for the PSMEs than regulator and regulatory management. Marketing has special relevance in the pharmaceutical industry as it deals with health and life saving issues for the people, and this got highlighted in our results. Three, the study found external management factors as the most followed coping / adaptation mechanism pursued by the PSMEs. Conforming to literature findings, our study also demonstrated smaller firms as significantly more vulnerable to adaptation in comparison with medium scale firms. The study also highlighted the attempt at balancing the local and global by the Indian PSMEs. While the process orientation was towards meeting international standards, the management of resources, marketing and regulatory requirements had a focus on the local pressures. The study provides some insight into the vulnerabilities and adaptation efforts of the Indian PSMEs and brings out the relevant strategic interventions needed from government, regulatory organizations and industry associations to develop a more sustainable business environment for the Indian PSMEs.en_US
dc.language.isoen_USen_US
dc.relation.ispartofseriesG25237en_US
dc.subjectPharmaceutical Industryen_US
dc.subjectPharmaceutical Small and Medium Enterprises (PSMEs)en_US
dc.subjectAnalytic Hierarchy Process (AHP)en_US
dc.subjectOperational Vulnerability Analysisen_US
dc.subjectEnvironmental Complianceen_US
dc.subjectAdaptation Mechanismen_US
dc.subject.classificationManagementen_US
dc.titleVulnerabilities And Adaptation To Environmental Regulations : Response Of Small And Medium Scale Firms In The Indian Pharmaceutical Industryen_US
dc.typeThesisen_US
dc.degree.namePhDen_US
dc.degree.levelDoctoralen_US
dc.degree.disciplineFaculty of Engineeringen_US


Files in this item

This item appears in the following Collection(s)

Show simple item record